• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PPD appoints Jonca Bull as VP PPD Consulting and ophthalmology

PPD appoints Jonca Bull as VP PPD Consulting and ophthalmology

October 3, 2017
CenterWatch Staff

Pharmaceutical Product Development (PPD) has appointed Jonca Bull, M.D., in a dual role as vice president of PPD Consulting, where she will serve as the head of regulatory consulting and as vice president, ophthalmology, within global product development.

Bull joined PPD from the FDA, where she most recently served as assistant commissioner and director of its Office of Minority Health.

“Jonca possesses a wealth of experience in the regulatory arena, including with the FDA and in the pharmaceutical industry,” said Rob Dow, chief medical officer for PPD. “Her experience working closely with pharmaceutical clients, as well as health and regulatory authorities, will help enhance patient engagement for PPD clients in developing life-changing therapies.”

PPD Consulting provides full drug development design and planning facilities, with broad experience of regulatory guidelines and the drug development process. Along with teams of consulting experts, the global product development teams coordinate multidisciplinary services and insight from therapeutic thought leaders to create customized development strategies to meet client needs.  

In the past five years, PPD’s dedicated global ophthalmology team has facilitated more than 65 trials, which have involved more than 9,000 patients and 1,400 investigative sites. The team’s comprehensive services include drug development and consulting in all functional areas of expertise to assist PPD’s clients.

Prior to joining the FDA, Bull was the vice president of U.S. regulatory policy for Novartis, and formerly worked at Genentech as the director of clinical regulatory policy.

Bull earned a bachelor’s degree from Princeton University and a medical degree from Duke University Medical School. She completed her residency in ophthalmology at George Washington University Hospital and is board certified.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing